-
Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Reduces Infarct Size Independently of Sodium Glucose Cotransporter-2
Chen, S., Wang, Q., Christodoulou, A., Mylonas, N., Bakker, D., Nederlof, R., Hollmann, M. W., Weber, N. C., Coronel, R., Wakker, V., Christoffels, V. M., Andreadou, I. & Zuurbier, C. J., 17 Jan 2023, In: Circulation. 147, 3, p. 276-279 4 p.Research output: Contribution to journal › Article › Academic › peer-review
-
The Redox Modulating Sonlicromanol Active Metabolite KH176m and the Antioxidant MPG Protect Against Short-Duration Cardiac Ischemia-Reperfusion Injury
Xiao, Y., Yim, K., Zhang, H., Bakker, D., Nederlof, R., Smeitink, J. A. M., Renkema, H., Hollmann, M. W., Weber, N. C. & Zuurbier, C. J., Aug 2021, In: Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy. 35, 4, p. 745-758 14 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Cardioprotecive Properties of Known Agents in Rat Ischemia-Reperfusion Model Under Clinically Relevant Conditions: Only the NAD Precursor Nicotinamide Riboside Reduces Infarct Size in Presence of Fentanyl, Midazolam and Cangrelor, but Not Propofol
Xiao, Y., Phelp, P., Wang, Q., Bakker, D., Nederlof, R., Hollmann, M. W. & Zuurbier, C. J., 2021, In: Frontiers in cardiovascular medicine. 8, p. 712478Research output: Contribution to journal › Article › Academic › peer-review
- All publications